Burjonroppa et al. first demonstrated that there is lack of association between markedly elevated BNP levels (>1,000 pg/mL) and clinical evidence of volume overload or LV dysfunction in cancer patients with multiple comorbidities (44). This evidence concerns the gene NPPB and cancer.